Intraocular Melanoma- Symptoms, Prognosis, Causes & Treatment

Quick Summary

• Intraocular melanoma is a rare cancer that forms in the pigment-producing cells (melanocytes) of the eye, most often in the uvea.
• Early signs of intraocular melanoma include blurred vision, floaters, flashes of light, and a change in pupil shape, often painless, which makes early detection tricky.
• Risk rises with age (50+), light-colored eyes, fair skin, and a history of skin or ocular moles.
• Diagnosis relies on eye exams, ultrasound, OCT imaging, and occasionally biopsy; no blood test can detect intraocular melanoma.
• Treatment ranges from laser therapy and radiation to surgery, with India offering advanced intraocular melanoma treatment at a fraction of Western costs.
• Survival rates for intraocular melanoma are highest (around 85%) when it’s caught before spreading beyond the eye.

Introduction

A dark spot in your vision or a sudden flash of light might seem harmless, but for a small number of people, it’s the first sign of intraocular melanoma, a rare cancer that grows quietly inside the eye. Because it often causes no pain and few obvious symptoms until later stages, many cases of intraocular melanoma are only found during a routine eye check-up, sometimes entirely by accident. In this guide, we’ll walk you through what intraocular melanoma actually is, the different forms it can take, the early warning signs to watch for, who’s most at risk, how doctors diagnose and treat it, and what the survival outlook looks like at each stage. If a loved one has just been diagnosed, we’ll also touch on how families in India are managing treatment costs, so you know what to expect and where to turn for support.

What Is Intraocular Melanoma?

Intraocular melanoma is a rare but serious eye cancer that develops in the melanocytes, the pigment-producing cells found throughout the eye, including the uvea, the eye’s middle layer sandwiched between the retina and the outer white layer (sclera). When these cells mutate and multiply uncontrollably, they form a tumour. Intraocular melanoma is the most common primary eye cancer in adults, though it remains rare overall, affecting roughly 5 to 6 people per million each year.

Unlike skin melanoma, intraocular melanoma isn’t usually caused by sun exposure alone, and it behaves quite differently in terms of growth pattern and spread. It can develop in three main parts of the eye, and where it forms often determines how it’s monitored and treated.

Types of Intraocular Melanoma

• Choroidal melanoma: The most common type, forming in the choroid, the layer rich in blood vessels that nourishes the retina. It’s also the type most likely to spread to other organs.
• Ciliary body melanoma: Develops in the ciliary body, the ring of tissue behind the iris that helps the eye focus. It tends to be diagnosed later since this area is harder to examine.
• Iris melanoma: Forms on the iris, the coloured part of the eye. It’s usually the least aggressive type and easiest to detect, since changes are often visible to the naked eye.

Intraocular Melanoma Symptoms: Early Warning Signs

Intraocular melanoma often develops silently, but as the tumour grows, it can trigger noticeable vision changes:

1. Blurred vision or sudden vision loss in one eye
2. Floaters – small dark shapes drifting across your field of vision
3. Flashes of light, similar to lightning streaks, in peripheral vision
4. Changes in pupil shape or size
5. Distorted vision, where straight lines appear wavy
6. Eye pain or pressure (less common, but possible)
7. A visible change in iris color or a new dark spot on the eye
8. Loss of peripheral vision, which some patients only notice while driving or reading

Because intraocular melanoma frequently causes no pain in its early stages, many people don’t realise anything is wrong until the tumour has grown large enough to affect vision. This is why routine eye exams remain the most reliable way to catch intraocular melanoma early, especially for people over 50, those with light-colored eyes, or anyone with a family history of eye or skin melanoma. If you notice any of these symptoms, especially a sudden onset, it’s worth getting an eye exam promptly rather than waiting to see if it resolves on its own.

Intraocular Melanoma Causes and Risk Factors

The exact cause of intraocular melanoma isn’t fully understood, but genetic mutations in melanocytes, sometimes linked to the BAP1 gene, play a central role. These mutations cause pigment-producing cells to divide uncontrollably, eventually forming a tumour. Several factors appear to increase this risk:

• Age: Intraocular melanoma is most common in people in their 50s and 60s, though it can occur at any age.
• Light eye color: People with blue or green eyes carry a slightly higher risk than those with darker eyes, likely due to lower melanin levels.
• Fair skin and moles: A history of skin melanoma, dysplastic nevus syndrome, or atypical moles elevates risk.
• Ocular melanocytosis: A condition marked by abnormal pigment cells in the uvea, increasing susceptibility.
• Family history: Inherited conditions and a family history of ocular melanoma raise the likelihood of developing it.
• Race: Caucasians are diagnosed with intraocular melanoma more often than other ethnic groups.
• Gender: There’s a slight male predominance in reported cases.
• Prior radiation exposure: Previous radiation therapy to the eye or head region has been linked to higher risk.

It’s worth noting that having one or more risk factors doesn’t mean someone will develop the condition; many patients have no identifiable risk factor at all, which is part of why regular eye screening matters regardless of perceived risk.

How Is Intraocular Melanoma Diagnosed?

Diagnosing intraocular melanoma typically starts with a comprehensive eye exam by an ophthalmologist, who examines both the external and internal structures of the eye using specialised equipment. This may reveal signs such as enlarged blood vessels on the eye’s surface, which can hint at a tumour growing inside. From there, imaging tests confirm the tumour’s size, shape, and exact location:

• Ultrasound: Uses high-frequency sound waves to create detailed images inside the eye, helping detect and measure the tumour even when it can’t be seen directly.
• Optical Coherence Tomography (OCT): A noninvasive scan that captures cross-sectional images of the eye, useful for observing how the tumour is affecting surrounding structures like the retina.
• Angiogram: Involves injecting a dye into the bloodstream so doctors can visualise blood vessels in and around the suspected tumour.
• Biopsy: Rarely performed due to the risks involved, but may be used when imaging results are inconclusive, and a tissue sample is needed to confirm the diagnosis.

In most cases, the condition can be diagnosed accurately through imaging alone, without needing an invasive biopsy, a key difference from many other cancers.

Intraocular Melanoma Treatment Options and Cost in India

Intraocular melanoma treatment depends on the tumour’s size, location, and the patient’s overall health, and India offers access to most major treatment types at costs considerably lower than in the US, UK, or other Western countries.

Surgery is often the first line of treatment. It may involve removing just the tumour or, in more advanced cases, the entire eye (a procedure called enucleation) to prevent the cancer from spreading further. Cost varies significantly based on the complexity of the surgery and the hospital chosen.

Laser therapy, such as Transpupillary Thermotherapy (TTT), uses focused heat to shrink the tumour. It’s less invasive than surgery, generally has fewer side effects, and works best for smaller tumours. Laser therapy for intraocular melanoma can start from as low as USD 500 (approximately INR 37,500) per eye, though this varies with the treatment plan.

Radiation therapy is one of the most common intraocular melanoma treatments, using radioactive material to destroy cancer cells while trying to preserve as much healthy eye tissue and vision as possible. It can be delivered externally or through brachytherapy, where tiny radioactive seeds are implanted near the tumour. Radiation does carry some risk of vision loss and other complications, particularly for larger tumours.

Chemotherapy is used less frequently for intraocular melanoma and is generally reserved for cases where cancer has spread beyond the eye. It can be administered orally or intravenously, depending on the treatment plan.

The total cost of intraocular melanoma treatment in India depends on the stage of cancer, the specific treatment combination required, and the hospital and specialist chosen. Patients are strongly advised to consult an ocular oncologist for a personalised diagnosis and a detailed cost breakdown before beginning treatment.

Intraocular Melanoma Survival Rate and Prognosis

The intraocular melanoma survival rate depends heavily on how early the cancer is caught and whether it has spread beyond the eye:

• Localised (confined to the eye): Approximately 85% five-year relative survival rate
• Regional spread (affecting nearby structures or lymph nodes): Approximately 67% five-year relative survival rate
• Distant metastasis (spread to organs like the liver): Approximately 16% five-year relative survival rate

These figures, drawn from the American Cancer Society’s SEER database, represent aggregate outcomes and can’t predict any single patient’s prognosis; age, overall health, tumour type, and response to treatment all play a role.

Research shows intraocular melanoma metastasises in roughly 40% to 50% of cases, with the liver being the most common site of spread in about 90% of those instances. The specific type of melanoma also influences this risk: choroidal and ciliary body melanomas are more prone to metastasis than iris melanomas, which tend to have a more favourable long-term outlook.

Ongoing follow-up care, including regular imaging and eye exams, remains essential even after successful treatment, both to monitor for local recurrence and to catch any spread early, when it’s most treatable.

Conclusion

Intraocular melanoma is rare, but early detection makes all the difference between a favourable outcome and a difficult one. Routine eye exams remain the best defense against the condition, especially for those over 50 or with light-colored eyes. If you or a loved one is navigating a diagnosis, remember that treatment, from laser therapy to surgery, is often more accessible in India than abroad, though costs can still add up quickly. This is where a trusted fundraising platform can help. Impact Guru, an online donation platform built for medical emergencies, lets families start a fundraiser website in minutes and reach donors across India through a reliable fundraising platform, so treatment decisions are guided by medical need, not financial strain.

Frequently Asked Questions